HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: clinchem.2005.065417v1 52/8/1552    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (7) Citing Articles via Google Scholar Google Scholar Articles by Krayenbuehl, P.-A. Articles by Schulthess, G. Search for Related Content PubMed PubMed Citation Articles by Krayenbuehl, P.-A. Articles by Schulthess, G. Related Collections Molecular Diagnostics and Genetics Endocrinology and Metabolism

Tumor Necrosis Factor- –308G>A Allelic Variant Modulates Iron Accumulation in Patients with Hereditary Hemochromatosis

¹ Medical Policlinic, Department of Internal Medicine;² Institute of Clinical Chemistry; and³ Department of Surgery, University Hospital of Zurich Switzerland.

^aAddress correspondence to this author at: Department of Internal Medicine, Medical Policlinic, University Hospital of Zurich, CH-8091 Zurich, Switzerland. Fax 0041-44-255-45-67; e-mail georg.schulthess{at}usz.ch.

Background: In vitro and animal studies suggest that tumor necrosis factor (TNF-) modulates intestinal iron transport. We hypothesized that the effect of TNF- might be particularly relevant if iron absorption is not effectively controlled by the HFE gene.

Methods: In patients with homozygous C282Y hemochromatosis, we investigated the influence of TNF- –308G>A allelic variant on total body iron overload, determined in all patients by measuring iron removed during depletion therapy, and hepatic iron index and need for phlebotomy to prevent iron reaccumulation, measured in patient subgroups.

Results: Of 86 patients with hereditary hemochromatosis, 16 (19%) were heterozygous carriers and 1 (1%) was a homozygous carrier of the TNF- promoter –308A allele. Mean (SD) total body iron overload was increased 2-fold in TNF- –308A allele carriers [10.9 (7.6) g] compared with homozygous carriers of the G allele [5.6 (5.0) g, P <0.001]. Hepatic iron index differed markedly between TNF- –308A allele carriers [5.6 (3.5) µmol/g/year] and homozygous G allele carriers [3.1 (2.2) µmol/g/year, P = 0.040, n = 30]. After iron depletion, the need for phlebotomy to prevent iron reaccumulation (maintenance therapy) was substantially higher in TNF- –308A allele carriers than in homozygous G allele carriers (P = 0.014, n = 73). We used multiple regression analyses to exclude possible confounding effects of sex, age, family screening, body-mass index, and meat or alcohol intake.

Conclusion: TNF- –308G>A allelic variant modulates iron accumulation in patients with hereditary (homozygous C282Y) hemochromatosis, but the effect of the TNF- –308A allele on clinical manifestations of hemochromatosis was less accentuated than expected from the increased iron load associated with this allele.

The following articles in journals at HighWire Press have cited this article:

				S. H. Atkinson, K. A. Rockett, G. Morgan, P. A. Bejon, G. Sirugo, M. A. O'Connell, N. Hanchard, D. P. Kwiatkowski, and A. M. Prentice Tumor necrosis factor SNP haplotypes are associated with iron deficiency anemia in West African children Blood, November 15, 2008; 112(10): 4276 - 4283. [Abstract] [Full Text] [PDF]